- Published on
Emergency and Acute Medicine – Disulfiram Reaction
Basics
Description
Disulfiram inhibits multiple enzymatic pathways, and its active metabolites contribute additional toxic effects. The classic disulfiram–ethanol reaction usually occurs 8–12 hours after drug ingestion and is not expected beyond 24 hours after dosing. Disulfiram competitively and irreversibly inhibits aldehyde dehydrogenase, blocking ethanol metabolism and causing accumulation of acetaldehyde. Acetaldehyde triggers histamine release, leading to vasodilation and hypotension. Severe reactions may occur at ethanol levels as low as 50–100 mg/dL, and severity correlates with the amount of ethanol consumed.
Disulfiram also inhibits dopamine β-hydroxylase, reducing conversion of dopamine to norepinephrine. Excess dopamine may contribute to behavioral changes, while norepinephrine depletion may worsen hypotension. Its metabolite, carbon disulfide, interferes with pyridoxal-5-phosphate, reducing pyridoxine availability for γ-aminobutyric acid synthesis and potentially lowering the seizure threshold. Carbon disulfide is additionally cardiotoxic, hepatotoxic, inhibits CYP2E1, chelates essential metals, and may cause dose- and duration-dependent peripheral neuropathy.
Etiology
Disulfiram is prescribed as a deterrent for chronic alcohol use disorder, and many patients wear medical alert identification. Disulfiram-like reactions may also occur with other agents, including metronidazole; certain cephalosporins with an N-methylthiotetrazole side chain such as cefoperazone, cefotetan, and cefmetazole; nitrofurantoin; sulfonylurea hypoglycemics; industrial exposures such as carbon disulfide and hydrogen sulfide; and mushrooms including Coprinus atramentarius and Clitocybe clavipes.
Diagnosis
Signs and symptoms
Disulfiram–ethanol reactions commonly present with hypotension, tachycardia, tachypnea, flushing of the face, neck, and torso, pruritus, diaphoresis, warmth, nausea, vomiting, abdominal pain, diarrhea, headache, ataxia, confusion, anxiety, and dizziness. Severe cases may involve dyspnea, pulmonary edema, chest pain, dysrhythmias, and myocardial infarction.
Disulfiram overdose is uncommon with ingestions under 3 g, while doses of 10–30 g may be fatal. Presentations may mimic shock or sepsis and include tachycardia, hypotension, tachypnea, abdominal pain, diarrhea, garlic- or rotten-egg breath, agitation, irritability, ataxia, dysarthria, hallucinations, lethargy, coma, seizures, flaccidity, or parkinsonian features.
History of disulfiram use, ingestion of causative agents, or ethanol exposure—including alcohol-containing foods, medications, or mouthwash—is key. Physical examination often reveals hemodynamic instability, flushing, diaphoresis, pulmonary edema, diffuse abdominal tenderness, altered mental status, cerebellar signs, or seizures.
Essential workup
Suspect a disulfiram–ethanol reaction when characteristic symptoms occur in a patient treated for alcohol use disorder with recent ethanol exposure.
Diagnosis tests and interpretation
Laboratory evaluation includes ethanol level, electrolytes, renal function, glucose, and liver function tests if hepatitis is suspected. Creatine phosphokinase should be checked if seizures or agitation raise concern for rhabdomyolysis. Urinalysis may detect myoglobin. Serum drug levels are not clinically useful.
Electrocardiography evaluates ischemia or dysrhythmias. Neuroimaging is indicated for altered mental status or seizures, as basal ganglia ischemia has been reported. EEG may show diffuse slowing in severe toxicity.
Differential diagnosis
Consider sepsis, meningitis or encephalitis, cardiogenic shock from acute coronary syndrome, anaphylactoid or anaphylactic reactions, gastroenteritis or pancreatitis with dehydration, and ethanol withdrawal.
Treatment
Prehospital care
Initial management includes airway assessment, intravenous access, fluid resuscitation if pulmonary edema is absent, and rapid glucose testing.
Initial stabilization and therapy
Provide airway protection as needed, supplemental oxygen, mechanical ventilation if required, aggressive isotonic fluid resuscitation for hypotension, and vasopressor support with norepinephrine for refractory shock.
Emergency department treatment and procedures
Management is primarily supportive, as no specific antidote exists. Activated charcoal may be considered after disulfiram overdose if the airway is protected and vomiting is controlled; gastric lavage and whole-bowel irrigation are not indicated. Flushing may be treated with antihistamines and prostaglandin inhibitors. Antiemetics are used for persistent vomiting. Seizures are treated with benzodiazepines, and pyridoxine supplementation is recommended.
Fomepizole is not indicated for routine reactions but may improve hemodynamics in severe overdoses. Hemodialysis may be considered after massive ingestion with refractory hypotension, though evidence of benefit is limited.
Medication
Commonly used agents include benzodiazepines for seizures, antihistamines for flushing and pruritus, antiemetics for nausea and vomiting, norepinephrine for refractory hypotension, and intravenous pyridoxine.
Follow-up and disposition
Admission criteria
Intensive care admission is required for coma, mechanical ventilation, refractory hypotension needing vasopressors, cardiac ischemia, uncontrolled seizures, severe agitation, persistent gastrointestinal symptoms, or in elderly patients and those with cardiac disease.
Discharge criteria
Patients with mild reactions that resolve after 8–12 hours of observation may be discharged. Ethanol abstinence is required for at least two weeks after the last dose of disulfiram or related agents, as reactions may recur for up to 7–10 days.
Follow-up recommendations
Psychiatric follow-up is indicated for intentional overdose, and detoxification or addiction follow-up is recommended after disulfiram–ethanol reactions to monitor for hepatic or neurologic sequelae.
Pearls and pitfalls
Patients prescribed disulfiram or drugs with disulfiram-like effects must avoid all alcohol sources, including mouthwash, hand sanitizers, aftershaves, cough syrups, and elixir-based medications. Abstinence should continue for several days beyond completion of therapy to minimize reaction risk.
Basics
Description
Disulfiram inhibits multiple enzymatic pathways, and its active metabolites contribute additional toxic effects. The classic disulfiram–ethanol reaction usually occurs 8–12 hours after drug ingestion and is not expected beyond 24 hours after dosing. Disulfiram competitively and irreversibly inhibits aldehyde dehydrogenase, blocking ethanol metabolism and causing accumulation of acetaldehyde. Acetaldehyde triggers histamine release, leading to vasodilation and hypotension. Severe reactions may occur at ethanol levels as low as 50–100 mg/dL, and severity correlates with the amount of ethanol consumed.
Disulfiram also inhibits dopamine β-hydroxylase, reducing conversion of dopamine to norepinephrine. Excess dopamine may contribute to behavioral changes, while norepinephrine depletion may worsen hypotension. Its metabolite, carbon disulfide, interferes with pyridoxal-5-phosphate, reducing pyridoxine availability for γ-aminobutyric acid synthesis and potentially lowering the seizure threshold. Carbon disulfide is additionally cardiotoxic, hepatotoxic, inhibits CYP2E1, chelates essential metals, and may cause dose- and duration-dependent peripheral neuropathy.
Etiology
Disulfiram is prescribed as a deterrent for chronic alcohol use disorder, and many patients wear medical alert identification. Disulfiram-like reactions may also occur with other agents, including metronidazole; certain cephalosporins with an N-methylthiotetrazole side chain such as cefoperazone, cefotetan, and cefmetazole; nitrofurantoin; sulfonylurea hypoglycemics; industrial exposures such as carbon disulfide and hydrogen sulfide; and mushrooms including Coprinus atramentarius and Clitocybe clavipes.
Diagnosis
Signs and symptoms
Disulfiram–ethanol reactions commonly present with hypotension, tachycardia, tachypnea, flushing of the face, neck, and torso, pruritus, diaphoresis, warmth, nausea, vomiting, abdominal pain, diarrhea, headache, ataxia, confusion, anxiety, and dizziness. Severe cases may involve dyspnea, pulmonary edema, chest pain, dysrhythmias, and myocardial infarction.
Disulfiram overdose is uncommon with ingestions under 3 g, while doses of 10–30 g may be fatal. Presentations may mimic shock or sepsis and include tachycardia, hypotension, tachypnea, abdominal pain, diarrhea, garlic- or rotten-egg breath, agitation, irritability, ataxia, dysarthria, hallucinations, lethargy, coma, seizures, flaccidity, or parkinsonian features.
History of disulfiram use, ingestion of causative agents, or ethanol exposure—including alcohol-containing foods, medications, or mouthwash—is key. Physical examination often reveals hemodynamic instability, flushing, diaphoresis, pulmonary edema, diffuse abdominal tenderness, altered mental status, cerebellar signs, or seizures.
Essential workup
Suspect a disulfiram–ethanol reaction when characteristic symptoms occur in a patient treated for alcohol use disorder with recent ethanol exposure.
Diagnosis tests and interpretation
Laboratory evaluation includes ethanol level, electrolytes, renal function, glucose, and liver function tests if hepatitis is suspected. Creatine phosphokinase should be checked if seizures or agitation raise concern for rhabdomyolysis. Urinalysis may detect myoglobin. Serum drug levels are not clinically useful.
Electrocardiography evaluates ischemia or dysrhythmias. Neuroimaging is indicated for altered mental status or seizures, as basal ganglia ischemia has been reported. EEG may show diffuse slowing in severe toxicity.
Differential diagnosis
Consider sepsis, meningitis or encephalitis, cardiogenic shock from acute coronary syndrome, anaphylactoid or anaphylactic reactions, gastroenteritis or pancreatitis with dehydration, and ethanol withdrawal.
Treatment
Prehospital care
Initial management includes airway assessment, intravenous access, fluid resuscitation if pulmonary edema is absent, and rapid glucose testing.
Initial stabilization and therapy
Provide airway protection as needed, supplemental oxygen, mechanical ventilation if required, aggressive isotonic fluid resuscitation for hypotension, and vasopressor support with norepinephrine for refractory shock.
Emergency department treatment and procedures
Management is primarily supportive, as no specific antidote exists. Activated charcoal may be considered after disulfiram overdose if the airway is protected and vomiting is controlled; gastric lavage and whole-bowel irrigation are not indicated. Flushing may be treated with antihistamines and prostaglandin inhibitors. Antiemetics are used for persistent vomiting. Seizures are treated with benzodiazepines, and pyridoxine supplementation is recommended.
Fomepizole is not indicated for routine reactions but may improve hemodynamics in severe overdoses. Hemodialysis may be considered after massive ingestion with refractory hypotension, though evidence of benefit is limited.
Medication
Commonly used agents include benzodiazepines for seizures, antihistamines for flushing and pruritus, antiemetics for nausea and vomiting, norepinephrine for refractory hypotension, and intravenous pyridoxine.
Follow-up and disposition
Admission criteria
Intensive care admission is required for coma, mechanical ventilation, refractory hypotension needing vasopressors, cardiac ischemia, uncontrolled seizures, severe agitation, persistent gastrointestinal symptoms, or in elderly patients and those with cardiac disease.
Discharge criteria
Patients with mild reactions that resolve after 8–12 hours of observation may be discharged. Ethanol abstinence is required for at least two weeks after the last dose of disulfiram or related agents, as reactions may recur for up to 7–10 days.
Follow-up recommendations
Psychiatric follow-up is indicated for intentional overdose, and detoxification or addiction follow-up is recommended after disulfiram–ethanol reactions to monitor for hepatic or neurologic sequelae.
Pearls and pitfalls
Patients prescribed disulfiram or drugs with disulfiram-like effects must avoid all alcohol sources, including mouthwash, hand sanitizers, aftershaves, cough syrups, and elixir-based medications. Abstinence should continue for several days beyond completion of therapy to minimize reaction risk.
0 Comments
